A total of one tumor had homozygous deletion at MLH1, two tumors had homozygous deletion at PMS2, two tumors had homozygous deletion at MSH2, one tumor had homozygous deletion at MSH6, and seven tumors had homozygous deletion at both MSH2 and MSH6. This evidence concerns the gene MSH6 and neoplasm.